Talk:Dean Burk
From Wikipedia, the free encyclopedia
FYI - HHS / NIH Press release
--News National Cancer Institute 1/24/2007
Positive results of a phase III cancer clinical trial in an uncommon form of leukemia were released today. The results showed that adult patients with previously untreated acute promyelocytic leukemia (APL) who had standard chemotherapy to induce remission of their disease, and then received the chemotherapy drug arsenic trioxide to maintain remission, had a significantly better event-free survival (more patients free of leukemia) and better overall survival than those who received only standard chemotherapy. The trial was sponsored by the National Cancer Institute (NCI), part of the National Institutes of Health, and was led by one of its Cooperative Clinical Trials Groups -- the Cancer and Leukemia Group B (CALGB).
What do you need? WikiMan53 T/C e@ edits 23:30, 27 January 2007 (UTC)
((helpme))
I can not get the picture that is in the "Commons" to appear and to have the caption. Thank you The Stroll 02:41, 31 January 2007 (UTC)